Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Sugamadex: Sugammadex 2mg/ kg will be administered for the reversal of rocuronium, monitored upto 30 min for complete recovery
Control Intervention1: Neostigmine: Neostigmine 0.05mg/kg
Sponsors
Pt BD Sharma, PGIMS
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients 1. aged between 18-60 years of 2. either sex, belonging to American Society of Anesthesiologists 3. (ASA) physical status I or II scheduled for elective surgery requiring general anaesthesia and 4. secured airway will be enrolled in the study
Exclusion criteria
Exclusion criteria: 1. Refusal to give consent 2.Patients with disorder of cardiovascular, hepatic, renal or neuromuscular system 3.Pregnant and lactating ladies 4.Known allergy to study drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| quality of recovery from neuromuscular blocker by using neostigmine or sugamadex, at30 sec,1 min, 2 min, 4 min NMB reversal to recovery of the TOF ratio to 0.9 •Extubation time Timepoint: quality of recovery from neuromuscular blocker by using neostigmine or sugamadex, at 30 sec, 1 min, 2 min, 4 min from NMB reversal to recovery of the TOF ratio to 0.9 •Extubation time | — |
Secondary
| Measure | Time frame |
|---|---|
| Aldrette scoreTimepoint: in recovery period | — |
Countries
India
Contacts
Public ContactPrashant Kumar
Pt BD Sharma PGIMS, Rohtak
Outcome results
None listed